| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 374.1K | $3.11M | - | |
| CEO | 305.4K | $2.54M | - | |
| VP | 202.2K | $1.68M | - | |
| VP | 185.6K | $1.54M | - | |
| VP | 162.1K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2016 | El-Hibri Fuad | Chairman | Sell | 25,000 | $38.71 | $967,750.00 | -1.5% | |
| May 12, 2016 | Hauer Jerome M | Director | Sale+OE | 4,700 | $38.50 | $180,950.00 | -25.0% | |
| May 11, 2016 | Sullivan Louis W62 | Director | Sale+OE | 9,969 | $39.25 | $391,283.25 | -25.9% | |
| Apr 22, 2016 | El-Hibri Fuad | Chairman | Sell | 4,209 | $40.50 | $170,464.50 | -0.2% | |
| Apr 18, 2016 | El-Hibri Fuad | Chairman | Sell | 20,791 | $40.50 | $842,035.50 | -1.2% | |
| Apr 18, 2016 | Abdun-Nabi Daniel | President &CEO | Sell | 8,702 | $40.17 | $349,559.34 | -1.5% | |
| Apr 6, 2016 | Kramer Robert | EVP, Corporate Services Divisi | Sale+OE | 21,786 | $38.90 | $847,475.40 | -5.8% | |
| Apr 6, 2016 | El-Hibri Fuad | Chairman | Sell | 50,000 | $39.00 | $1,950,000.00 | -1.4% | |
| Apr 4, 2016 | Kramer Robert | EVP, Corporate Services Divisi | Sale+OE | 21,788 | $36.90 | $803,977.20 | -5.5% | |
| Apr 1, 2016 | Kramer Robert | EVP, Corporate Services Divisi | Sale+OE | 43,572 | $35.56 | $1,549,594.65 | -7.3% |